MEDIPOST Co. Ltd (078160) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.054x

Based on the latest financial reports, MEDIPOST Co. Ltd (078160) has a cash flow conversion efficiency ratio of -0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-14.44 Billion ≈ $-9.78 Million USD) by net assets (₩265.17 Billion ≈ $179.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 078160 stock market capitalisation for the company's overall valuation and market capitalisation.

MEDIPOST Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how MEDIPOST Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MEDIPOST Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDIPOST Co. Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of MEDIPOST Co. Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
CFSB Bancorp Inc NASDAQ:CFSB	0.001x
Nanjing Panda Electronics Company Limited F:NNJ	0.013x
Podak Co Ltd TWO:3537	0.023x
Positivo Tecnologia S.A SA:POSI3	0.073x
Premier Polyfilm Limited NSE:PREMIERPOL	0.116x
Sona Topas Tourism Industry JK:SONA	0.066x
Syntec Construction Public Company Limited BK:SYNTEC	-0.046x
Codes Combine Co. Ltd KQ:047770	-0.020x

Annual Cash Flow Conversion Efficiency for MEDIPOST Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of MEDIPOST Co. Ltd from 2011 to 2024. View MEDIPOST Co. Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩252.60 Billion ≈ $171.18 Million	₩-37.27 Billion ≈ $-25.25 Million	-0.148x	-142.55%
2023-12-31	₩313.66 Billion ≈ $212.56 Million	₩-19.08 Billion ≈ $-12.93 Million	-0.061x	-76.79%
2022-12-31	₩179.97 Billion ≈ $121.96 Million	₩-6.19 Billion ≈ $-4.20 Million	-0.034x	-235.26%
2021-12-31	₩159.48 Billion ≈ $108.08 Million	₩4.06 Billion ≈ $2.75 Million	0.025x	+66.11%
2020-12-31	₩116.54 Billion ≈ $78.98 Million	₩1.78 Billion ≈ $1.21 Million	0.015x	-77.26%
2019-12-31	₩111.59 Billion ≈ $75.62 Million	₩7.51 Billion ≈ $5.09 Million	0.067x	+23.88%
2018-12-31	₩126.81 Billion ≈ $85.94 Million	₩6.89 Billion ≈ $4.67 Million	0.054x	+181.97%
2017-12-31	₩104.45 Billion ≈ $70.78 Million	₩-6.93 Billion ≈ $-4.69 Million	-0.066x	+23.49%
2016-12-31	₩143.31 Billion ≈ $97.12 Million	₩-12.42 Billion ≈ $-8.42 Million	-0.087x	-83.84%
2015-12-31	₩146.48 Billion ≈ $99.27 Million	₩-6.91 Billion ≈ $-4.68 Million	-0.047x	-270.60%
2014-12-31	₩117.34 Billion ≈ $79.52 Million	₩-1.49 Billion ≈ $-1.01 Million	-0.013x	-229.63%
2011-12-31	₩115.04 Billion ≈ $77.96 Million	₩1.13 Billion ≈ $765.03K	0.010x	--

About MEDIPOST Co. Ltd

KQ:078160 Korea Biotechnology & Medical Research

Market Cap

$93.28 Million

₩137.65 Billion KRW

Market Cap Rank

#19531 Global

#984 in Korea

Share Price

₩8950.00

Change (1 day)

+3.23%

52-Week Range

₩7520.00 - ₩28000.00

All Time High

₩72522.12